GH Research Statistics
Total Valuation
GH Research has a market cap or net worth of $669.59 million. The enterprise value is $346.54 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GH Research has 62.03 million shares outstanding. The number of shares has increased by 3.25% in one year.
| Current Share Class | 62.03M |
| Shares Outstanding | 62.03M |
| Shares Change (YoY) | +3.25% |
| Shares Change (QoQ) | +9.37% |
| Owned by Insiders (%) | 33.88% |
| Owned by Institutions (%) | 19.11% |
| Float | 20.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.98 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.71, with a Debt / Equity ratio of 0.00.
| Current Ratio | 29.71 |
| Quick Ratio | 29.38 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -71.95 |
Financial Efficiency
Return on equity (ROE) is -16.20% and return on invested capital (ROIC) is -12.35%.
| Return on Equity (ROE) | -16.20% |
| Return on Assets (ROA) | -11.97% |
| Return on Invested Capital (ROIC) | -12.35% |
| Return on Capital Employed (ROCE) | -16.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$842,140 |
| Employee Count | 50 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.26% in the last 52 weeks. The beta is 0.86, so GH Research's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -8.26% |
| 50-Day Moving Average | 10.35 |
| 200-Day Moving Average | 9.64 |
| Relative Strength Index (RSI) | 57.81 |
| Average Volume (20 Days) | 144,964 |
Short Selling Information
The latest short interest is 2.88 million, so 4.64% of the outstanding shares have been sold short.
| Short Interest | 2.88M |
| Short Previous Month | 2.77M |
| Short % of Shares Out | 4.64% |
| Short % of Float | 13.97% |
| Short Ratio (days to cover) | 13.87 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -51.52M |
| Pretax Income | -32.32M |
| Net Income | -42.11M |
| EBITDA | -51.46M |
| EBIT | -51.52M |
| Earnings Per Share (EPS) | -$0.79 |
Full Income StatementBalance Sheet
The company has $291.35 million in cash and $658,000 in debt, giving a net cash position of $314.68 million or $5.07 per share.
| Cash & Cash Equivalents | 291.35M |
| Total Debt | 658,000 |
| Net Cash | 314.68M |
| Net Cash Per Share | $5.07 |
| Equity (Book Value) | 310.21M |
| Book Value Per Share | 5.45 |
| Working Capital | 284.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$41.26 million and capital expenditures -$41,000, giving a free cash flow of -$41.30 million.
| Operating Cash Flow | -41.26M |
| Capital Expenditures | -41,000 |
| Free Cash Flow | -41.30M |
| FCF Per Share | -$0.67 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |